Opus Genetics, Inc. Payments to Acquire Marketable Securities
Opus Genetics, Inc. (IRD) reported Payments to Acquire Marketable Securities of $8.89 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2020-10-29
- Opus Genetics, Inc. payments to acquire marketable securities for the quarter ending 2019-12-31 was $0.00.
- Opus Genetics, Inc. payments to acquire marketable securities for the quarter ending 2019-09-30 was $0.00.
- Opus Genetics, Inc. payments to acquire marketable securities for the quarter ending 2019-06-30 was $0.00.
- Opus Genetics, Inc. payments to acquire marketable securities for the quarter ending 2019-03-31 was $8.89M.
- Opus Genetics, Inc. payments to acquire marketable securities for fiscal 2019 was $8.89M.
- Opus Genetics, Inc. payments to acquire marketable securities for fiscal 2017 was $21.02M, a 140.27% increase from fiscal 2016.
- Opus Genetics, Inc. payments to acquire marketable securities for fiscal 2016 was $8.75M, a 10.61% increase from fiscal 2015.
- Opus Genetics, Inc. payments to acquire marketable securities for fiscal 2015 was $7.91M, a 69.67% decline from fiscal 2014.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 132 month | Payments to Acquire Marketable Securities 135 month | Payments to Acquire Marketable Securities 138 month | Payments to Acquire Marketable Securities 141 month | Payments to Acquire Marketable Securities 144 month | Payments to Acquire Marketable Securities 147 month | Payments to Acquire Marketable Securities 150 month | Payments to Acquire Marketable Securities 153 month | Payments to Acquire Marketable Securities 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 derived: sum of 3 quarters · filed 2020-10-29 | $8.89M 10-K · filed 2020-02-21 | |||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $8.89M 10-Q · filed 2020-10-29 | ||||||||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $8.89M 10-Q · filed 2020-08-14 | |||||||||||
| 2019-03-31 | $8.89M 10-Q · filed 2020-05-07 | ||||||||||||
| 2017-12-31 | $6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $6.01M derived: sum of 2 quarters · filed 2019-03-07 | $19.01M derived: sum of 3 quarters · filed 2019-03-07 | $21.02M 10-K · filed 2019-03-07 | |||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $13.00M derived: sum of 2 quarters · filed 2018-11-02 | $15.01M 10-Q · filed 2018-11-02 | $15.01M derived: sum of 4 quarters · filed 2018-11-02 | |||||||||
| 2017-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $15.01M 10-Q · filed 2018-08-03 | $15.01M derived: sum of 3 quarters · filed 2018-08-03 | $22.03M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | $2.01M 10-Q · filed 2018-05-04 | $2.01M derived: sum of 2 quarters · filed 2018-05-04 | $9.03M derived: sum of 3 quarters · filed 2018-05-04 | $9.03M derived: sum of 4 quarters · filed 2018-05-04 | |||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $7.03M derived: sum of 2 quarters · filed 2018-03-09 | $7.03M derived: sum of 3 quarters · filed 2018-03-09 | $8.75M 10-K · filed 2018-03-09 | |||||||||
| 2016-09-30 | $7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $7.03M derived: sum of 2 quarters · filed 2017-11-03 | $8.75M 10-Q · filed 2017-11-03 | $15.91M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $1.72M 10-Q · filed 2017-08-04 | $8.89M derived: sum of 3 quarters · filed 2018-03-09 | $8.89M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-03-31 | $1.72M 10-Q · filed 2017-05-03 | $8.89M derived: sum of 2 quarters · filed 2018-03-09 | $8.89M derived: sum of 3 quarters · filed 2018-03-09 | $8.89M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2015-12-31 | $7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $7.17M derived: sum of 2 quarters · filed 2018-03-09 | $7.17M derived: sum of 3 quarters · filed 2018-03-09 | $7.91M 10-K · filed 2018-03-09 | |||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $740.83K 10-Q · filed 2016-11-04 | $6.26M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $740.83K 10-Q · filed 2016-08-05 | $6.26M derived: sum of 3 quarters · filed 2017-02-24 | ||||||||||
| 2015-03-31 | $740.83K 10-Q · filed 2016-05-06 | $6.26M derived: sum of 2 quarters · filed 2017-02-24 | |||||||||||
| 2014-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $26.08M 10-K · filed 2017-02-24 | |||||||||||
| 2014-09-30 | $20.56M 10-Q · filed 2015-11-02 | ||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 156 month − 10-K 153 month · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $21.12M 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $0.00 derived: 10-K 153 month − 10-Q 150 month · filed 2014-03-21 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 derived: sum of 4 quarters · filed 2014-03-21 | $21.12M 10-K · filed 2014-03-21 | ||||||||
| 2013-09-30 | $0.00 derived: 10-Q 150 month − 10-Q 147 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 derived: sum of 3 quarters · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-13 | $21.12M 10-Q · filed 2013-11-13 | ||||||||
| 2013-06-30 | $0.00 derived: 10-Q 147 month − 10-Q 144 month · filed 2013-08-12 | $0.00 derived: sum of 2 quarters · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2013-08-12 | $0.00 derived: sum of 4 quarters · filed 2013-08-12 | $21.12M 10-Q · filed 2013-08-12 | ||||||||
| 2013-03-31 | $0.00 derived: 10-Q 144 month − 10-K 141 month · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | $21.12M 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 141 month − 10-Q 138 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $21.12M 10-K · filed 2013-03-22 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 138 month − 10-Q 135 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $21.12M 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 135 month − 10-Q 132 month · filed 2012-08-08 | $0.00 derived: sum of 2 quarters · filed 2012-08-08 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $21.12M 10-Q · filed 2012-08-08 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $8.00M derived: sum of 4 quarters · filed 2013-03-22 | $21.12M 10-Q · filed 2012-05-09 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $8.00M derived: sum of 3 quarters · filed 2013-03-22 | $8.00M 10-K · filed 2013-03-22 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $8.00M derived: sum of 2 quarters · filed 2012-11-08 | $8.00M 10-Q · filed 2012-11-08 | $9.85M derived: sum of 4 quarters · filed 2012-11-08 | |||||||||
| 2011-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $8.00M 10-Q · filed 2012-08-08 | $9.85M derived: sum of 3 quarters · filed 2012-08-08 | $10.35M derived: sum of 4 quarters · filed 2012-08-08 | |||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-09 | $1.85M derived: sum of 2 quarters · filed 2012-05-09 | $2.35M derived: sum of 3 quarters · filed 2012-05-09 | ||||||||||
| 2010-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $2.35M derived: sum of 2 quarters · filed 2012-03-16 | $2.35M 10-K · filed 2012-03-16 | ||||||||||
| 2010-09-30 | $503.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $503.96K 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | $1.37M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |